Estimands and estimators of two-level methods using return to baseline strategy for longitudinal clinical trials with incomplete daily patient reported outcomes

被引:3
作者
Jin, Man [1 ]
Liu, Guanghan [2 ]
机构
[1] AbbVie Inc, Data & Stat Sci, N Chicago, IL USA
[2] Merck & Co Inc, Biostat & Res Decis Sci, N Wales, PA USA
关键词
Missing not at random; multiple imputations; reference-based imputation; return to baseline; PROTOCOL;
D O I
10.1080/10543406.2021.1934855
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Returning to baseline (RTB) has been a practical method for handling missing data. Here we consider longitudinal clinical trials with daily patient reported outcomes (PROs), where efficacy endpoints are often defined as the average daily values in a cycle (such as a month or a week). The conventional method treats data at cycle level and ignores daily values. In this paper, we build a two-level constrained longitudinal data analysis (cLDA) model on daily values and propose two-level RTB method to impute daily values. Standard multiple imputation (MI) approach and likelihood-based approach are proposed and evaluated by simulations.
引用
收藏
页码:425 / 438
页数:14
相关论文
共 14 条
  • [1] ANALYSIS OF LONGITUDINAL TRIALS WITH PROTOCOL DEVIATION: A FRAMEWORK FOR RELEVANT, ACCESSIBLE ASSUMPTIONS, AND INFERENCE VIA MULTIPLE IMPUTATION
    Carpenter, James R.
    Roger, James H.
    Kenward, Michael G.
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2013, 23 (06) : 1352 - 1371
  • [2] Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
    Herring, W. Joseph
    Connor, Kathryn M.
    Ivgy-May, Neely
    Snyder, Ellen
    Liu, Ken
    Snavely, Duane B.
    Krystal, Andrew D.
    Walsh, James K.
    Benca, Ruth M.
    Rosenberg, Russell
    Sangal, R. Bart
    Budd, Kerry
    Hutzelmann, Jill
    Leibensperger, Heather
    Froman, Samar
    Lines, Christopher
    Roth, Thomas
    Michelson, David
    [J]. BIOLOGICAL PSYCHIATRY, 2016, 79 (02) : 136 - 148
  • [3] ICH, 2019, ICH harmonised guidelineM9: biopharmaceutics classification system-based biowaivers
  • [4] Two-level approaches to missing data in longitudinal trials with daily patient-reported outcomes
    Jin, Man
    Feng, Dai
    Liu, Guanghan
    Wan, Shuyan
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2020, 29 (07) : 1935 - 1949
  • [5] Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial
    Kingsbury, Sarah R.
    Tharmanathan, Puvan
    Arden, Nigel K.
    Batley, Michael
    Birrell, Fraser
    Cocks, Kim
    Doherty, Michael
    Edwards, Chris J.
    Garrood, Toby
    Grainger, Andrew J.
    Green, Michael
    Hewitt, Catherine
    Hughes, Rod
    Moots, Robert
    O'Neill, Terence W.
    Roddy, Edward
    Scott, David L.
    Watt, Fiona E.
    Torgerson, David J.
    Conaghan, Philip G.
    [J]. TRIALS, 2015, 16
  • [6] Intent-to-treat analysis for longitudinal studies with drop-outs
    Little, R
    Yau, L
    [J]. BIOMETRICS, 1996, 52 (04) : 1324 - 1333
  • [7] Little R.J., 2019, STAT ANAL MISSING DA, V793
  • [8] PATTERN-MIXTURE MODELS FOR MULTIVARIATE INCOMPLETE DATA
    LITTLE, RJA
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1993, 88 (421) : 125 - 134
  • [9] On analysis of longitudinal clinical trials with missing data using reference-based imputation
    Liu, G. Frank
    Pang, Lei
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2016, 26 (05) : 924 - 936
  • [10] Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?
    Liu, Guanghan F.
    Lu, Kaifeng
    Mogg, Robin
    Mallick, Madhuja
    Mehrotra, Devan V.
    [J]. STATISTICS IN MEDICINE, 2009, 28 (20) : 2509 - 2530